Mimedx (MDXG) Asset Writedowns and Impairment (2016 - 2026)

Mimedx has disclosed Asset Writedowns and Impairment across 11 years of filings, most recently posting $5.3 million for Q2 2026.

• In Q2 2026, Asset Writedowns and Impairment rose 1404.56% year-over-year to $5.3 million; the TTM figure through Jun 2026 stood at $12.2 million (up 859.54% YoY), while the FY2025 annual figure was $6.5 million, up 994.96% from the prior year.
• Asset Writedowns and Impairment came in at $5.3 million for Q2 2026 at Mimedx, up from $1.5 million in the prior quarter.
• In the past five years, Asset Writedowns and Impairment ranged from a high of $5.3 million in Q2 2026 to a low of -$279000.0 in Q3 2024.
• Average Asset Writedowns and Impairment over 5 years is $1.1 million, with a median of $447000.0 recorded in 2023.
• Year-over-year, Asset Writedowns and Impairment jumped 23633.33% in 2023 and slumped 162.42% in 2024.
• Over 5 years, Asset Writedowns and Impairment stood at $3000.0 in 2022, then jumped by 23633.33% to $712000.0 in 2023, then slumped by 36.24% to $454000.0 in 2024, then jumped by 641.41% to $3.4 million in 2025, then soared by 56.89% to $5.3 million in 2026.
• Per Business Quant data, the three most recent Asset Writedowns and Impairment figures were $5.3 million in Q2 2026, $1.5 million in Q1 2026, and $3.4 million in Q4 2025.